Price Chart

Profile

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
URL https://www.vtvtherapeutics.com
Investor Relations URL https://ir.vtvtherapeutics.com/
HQ State/Province North Carolina
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Nov. 08, 2024 (est.)
Last Earnings Release Aug. 08, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
URL https://www.vtvtherapeutics.com
Investor Relations URL https://ir.vtvtherapeutics.com/
HQ State/Province North Carolina
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Nov. 08, 2024 (est.)
Last Earnings Release Aug. 08, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A